Global Cell and Gene Therapy CDMO Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Cell and Gene Therapy CDMO market size was valued at US$ million in 2022. With growing demand in downstream market, the Cell and Gene Therapy CDMO is forecast to a readjusted size of US$ million by 2029 with a CAGR of % during review period.
The research report highlights the growth potential of the global Cell and Gene Therapy CDMO market. Cell and Gene Therapy CDMO are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Cell and Gene Therapy CDMO. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Cell and Gene Therapy CDMO market.
Key Features:
The report on Cell and Gene Therapy CDMO market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Cell and Gene Therapy CDMO market. It may include historical data, market segmentation by Type (e.g., Clinical Trial Material CDMOs, Development and Manufacturing CDMOs), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Cell and Gene Therapy CDMO market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Cell and Gene Therapy CDMO market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Cell and Gene Therapy CDMO industry. This include advancements in Cell and Gene Therapy CDMO technology, Cell and Gene Therapy CDMO new entrants, Cell and Gene Therapy CDMO new investment, and other innovations that are shaping the future of Cell and Gene Therapy CDMO.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Cell and Gene Therapy CDMO market. It includes factors influencing customer ' purchasing decisions, preferences for Cell and Gene Therapy CDMO product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Cell and Gene Therapy CDMO market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Cell and Gene Therapy CDMO market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Cell and Gene Therapy CDMO market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Cell and Gene Therapy CDMO industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Cell and Gene Therapy CDMO market.
Market Segmentation:
Cell and Gene Therapy CDMO market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Cell and Gene Therapy CDMO market size was valued at US$ million in 2022. With growing demand in downstream market, the Cell and Gene Therapy CDMO is forecast to a readjusted size of US$ million by 2029 with a CAGR of % during review period.
The research report highlights the growth potential of the global Cell and Gene Therapy CDMO market. Cell and Gene Therapy CDMO are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Cell and Gene Therapy CDMO. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Cell and Gene Therapy CDMO market.
Key Features:
The report on Cell and Gene Therapy CDMO market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Cell and Gene Therapy CDMO market. It may include historical data, market segmentation by Type (e.g., Clinical Trial Material CDMOs, Development and Manufacturing CDMOs), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Cell and Gene Therapy CDMO market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Cell and Gene Therapy CDMO market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Cell and Gene Therapy CDMO industry. This include advancements in Cell and Gene Therapy CDMO technology, Cell and Gene Therapy CDMO new entrants, Cell and Gene Therapy CDMO new investment, and other innovations that are shaping the future of Cell and Gene Therapy CDMO.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Cell and Gene Therapy CDMO market. It includes factors influencing customer ' purchasing decisions, preferences for Cell and Gene Therapy CDMO product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Cell and Gene Therapy CDMO market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Cell and Gene Therapy CDMO market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Cell and Gene Therapy CDMO market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Cell and Gene Therapy CDMO industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Cell and Gene Therapy CDMO market.
Market Segmentation:
Cell and Gene Therapy CDMO market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Clinical Trial Material CDMOs
- Development and Manufacturing CDMOs
- Other
- Pharmaceutical Company
- Biotechnology Company
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Lonza
- Charles River Laboratories
- Cytiva
- Catalent Biologics
- FUJIFILM Diosynth Biotechnologies
- BioCentriq
- RoslinCT
- Thermo Scientific
- Mesoblast
- Cellularity
- Bluebird Bio
- Editas Medicine
- Andelyn Biosciences
- Wuxi Advanced Therapies
- AGC Biologics
- Pfizer CentreOne
- Almac Group
- PCI Pharma Services
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Cell and Gene Therapy CDMO Market Size 2018-2029
2.1.2 Cell and Gene Therapy CDMO Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Cell and Gene Therapy CDMO Segment by Type
2.2.1 Clinical Trial Material CDMOs
2.2.2 Development and Manufacturing CDMOs
2.2.3 Other
2.3 Cell and Gene Therapy CDMO Market Size by Type
2.3.1 Cell and Gene Therapy CDMO Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Cell and Gene Therapy CDMO Market Size Market Share by Type (2018-2023)
2.4 Cell and Gene Therapy CDMO Segment by Application
2.4.1 Pharmaceutical Company
2.4.2 Biotechnology Company
2.4.3 Other
2.5 Cell and Gene Therapy CDMO Market Size by Application
2.5.1 Cell and Gene Therapy CDMO Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Cell and Gene Therapy CDMO Market Size Market Share by Application (2018-2023)
3 CELL AND GENE THERAPY CDMO MARKET SIZE BY PLAYER
3.1 Cell and Gene Therapy CDMO Market Size Market Share by Players
3.1.1 Global Cell and Gene Therapy CDMO Revenue by Players (2018-2023)
3.1.2 Global Cell and Gene Therapy CDMO Revenue Market Share by Players (2018-2023)
3.2 Global Cell and Gene Therapy CDMO Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CELL AND GENE THERAPY CDMO BY REGIONS
4.1 Cell and Gene Therapy CDMO Market Size by Regions (2018-2023)
4.2 Americas Cell and Gene Therapy CDMO Market Size Growth (2018-2023)
4.3 APAC Cell and Gene Therapy CDMO Market Size Growth (2018-2023)
4.4 Europe Cell and Gene Therapy CDMO Market Size Growth (2018-2023)
4.5 Middle East & Africa Cell and Gene Therapy CDMO Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Cell and Gene Therapy CDMO Market Size by Country (2018-2023)
5.2 Americas Cell and Gene Therapy CDMO Market Size by Type (2018-2023)
5.3 Americas Cell and Gene Therapy CDMO Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cell and Gene Therapy CDMO Market Size by Region (2018-2023)
6.2 APAC Cell and Gene Therapy CDMO Market Size by Type (2018-2023)
6.3 APAC Cell and Gene Therapy CDMO Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Cell and Gene Therapy CDMO by Country (2018-2023)
7.2 Europe Cell and Gene Therapy CDMO Market Size by Type (2018-2023)
7.3 Europe Cell and Gene Therapy CDMO Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Cell and Gene Therapy CDMO by Region (2018-2023)
8.2 Middle East & Africa Cell and Gene Therapy CDMO Market Size by Type (2018-2023)
8.3 Middle East & Africa Cell and Gene Therapy CDMO Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CELL AND GENE THERAPY CDMO MARKET FORECAST
10.1 Global Cell and Gene Therapy CDMO Forecast by Regions (2024-2029)
10.1.1 Global Cell and Gene Therapy CDMO Forecast by Regions (2024-2029)
10.1.2 Americas Cell and Gene Therapy CDMO Forecast
10.1.3 APAC Cell and Gene Therapy CDMO Forecast
10.1.4 Europe Cell and Gene Therapy CDMO Forecast
10.1.5 Middle East & Africa Cell and Gene Therapy CDMO Forecast
10.2 Americas Cell and Gene Therapy CDMO Forecast by Country (2024-2029)
10.2.1 United States Cell and Gene Therapy CDMO Market Forecast
10.2.2 Canada Cell and Gene Therapy CDMO Market Forecast
10.2.3 Mexico Cell and Gene Therapy CDMO Market Forecast
10.2.4 Brazil Cell and Gene Therapy CDMO Market Forecast
10.3 APAC Cell and Gene Therapy CDMO Forecast by Region (2024-2029)
10.3.1 China Cell and Gene Therapy CDMO Market Forecast
10.3.2 Japan Cell and Gene Therapy CDMO Market Forecast
10.3.3 Korea Cell and Gene Therapy CDMO Market Forecast
10.3.4 Southeast Asia Cell and Gene Therapy CDMO Market Forecast
10.3.5 India Cell and Gene Therapy CDMO Market Forecast
10.3.6 Australia Cell and Gene Therapy CDMO Market Forecast
10.4 Europe Cell and Gene Therapy CDMO Forecast by Country (2024-2029)
10.4.1 Germany Cell and Gene Therapy CDMO Market Forecast
10.4.2 France Cell and Gene Therapy CDMO Market Forecast
10.4.3 UK Cell and Gene Therapy CDMO Market Forecast
10.4.4 Italy Cell and Gene Therapy CDMO Market Forecast
10.4.5 Russia Cell and Gene Therapy CDMO Market Forecast
10.5 Middle East & Africa Cell and Gene Therapy CDMO Forecast by Region (2024-2029)
10.5.1 Egypt Cell and Gene Therapy CDMO Market Forecast
10.5.2 South Africa Cell and Gene Therapy CDMO Market Forecast
10.5.3 Israel Cell and Gene Therapy CDMO Market Forecast
10.5.4 Turkey Cell and Gene Therapy CDMO Market Forecast
10.5.5 GCC Countries Cell and Gene Therapy CDMO Market Forecast
10.6 Global Cell and Gene Therapy CDMO Forecast by Type (2024-2029)
10.7 Global Cell and Gene Therapy CDMO Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Lonza
11.1.1 Lonza Company Information
11.1.2 Lonza Cell and Gene Therapy CDMO Product Offered
11.1.3 Lonza Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Lonza Main Business Overview
11.1.5 Lonza Latest Developments
11.2 Charles River Laboratories
11.2.1 Charles River Laboratories Company Information
11.2.2 Charles River Laboratories Cell and Gene Therapy CDMO Product Offered
11.2.3 Charles River Laboratories Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Charles River Laboratories Main Business Overview
11.2.5 Charles River Laboratories Latest Developments
11.3 Cytiva
11.3.1 Cytiva Company Information
11.3.2 Cytiva Cell and Gene Therapy CDMO Product Offered
11.3.3 Cytiva Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Cytiva Main Business Overview
11.3.5 Cytiva Latest Developments
11.4 Catalent Biologics
11.4.1 Catalent Biologics Company Information
11.4.2 Catalent Biologics Cell and Gene Therapy CDMO Product Offered
11.4.3 Catalent Biologics Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Catalent Biologics Main Business Overview
11.4.5 Catalent Biologics Latest Developments
11.5 FUJIFILM Diosynth Biotechnologies
11.5.1 FUJIFILM Diosynth Biotechnologies Company Information
11.5.2 FUJIFILM Diosynth Biotechnologies Cell and Gene Therapy CDMO Product Offered
11.5.3 FUJIFILM Diosynth Biotechnologies Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 FUJIFILM Diosynth Biotechnologies Main Business Overview
11.5.5 FUJIFILM Diosynth Biotechnologies Latest Developments
11.6 BioCentriq
11.6.1 BioCentriq Company Information
11.6.2 BioCentriq Cell and Gene Therapy CDMO Product Offered
11.6.3 BioCentriq Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 BioCentriq Main Business Overview
11.6.5 BioCentriq Latest Developments
11.7 RoslinCT
11.7.1 RoslinCT Company Information
11.7.2 RoslinCT Cell and Gene Therapy CDMO Product Offered
11.7.3 RoslinCT Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 RoslinCT Main Business Overview
11.7.5 RoslinCT Latest Developments
11.8 Thermo Scientific
11.8.1 Thermo Scientific Company Information
11.8.2 Thermo Scientific Cell and Gene Therapy CDMO Product Offered
11.8.3 Thermo Scientific Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Thermo Scientific Main Business Overview
11.8.5 Thermo Scientific Latest Developments
11.9 Mesoblast
11.9.1 Mesoblast Company Information
11.9.2 Mesoblast Cell and Gene Therapy CDMO Product Offered
11.9.3 Mesoblast Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Mesoblast Main Business Overview
11.9.5 Mesoblast Latest Developments
11.10 Cellularity
11.10.1 Cellularity Company Information
11.10.2 Cellularity Cell and Gene Therapy CDMO Product Offered
11.10.3 Cellularity Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Cellularity Main Business Overview
11.10.5 Cellularity Latest Developments
11.11 Bluebird Bio
11.11.1 Bluebird Bio Company Information
11.11.2 Bluebird Bio Cell and Gene Therapy CDMO Product Offered
11.11.3 Bluebird Bio Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Bluebird Bio Main Business Overview
11.11.5 Bluebird Bio Latest Developments
11.12 Editas Medicine
11.12.1 Editas Medicine Company Information
11.12.2 Editas Medicine Cell and Gene Therapy CDMO Product Offered
11.12.3 Editas Medicine Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Editas Medicine Main Business Overview
11.12.5 Editas Medicine Latest Developments
11.13 Andelyn Biosciences
11.13.1 Andelyn Biosciences Company Information
11.13.2 Andelyn Biosciences Cell and Gene Therapy CDMO Product Offered
11.13.3 Andelyn Biosciences Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Andelyn Biosciences Main Business Overview
11.13.5 Andelyn Biosciences Latest Developments
11.14 Wuxi Advanced Therapies
11.14.1 Wuxi Advanced Therapies Company Information
11.14.2 Wuxi Advanced Therapies Cell and Gene Therapy CDMO Product Offered
11.14.3 Wuxi Advanced Therapies Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Wuxi Advanced Therapies Main Business Overview
11.14.5 Wuxi Advanced Therapies Latest Developments
11.15 AGC Biologics
11.15.1 AGC Biologics Company Information
11.15.2 AGC Biologics Cell and Gene Therapy CDMO Product Offered
11.15.3 AGC Biologics Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 AGC Biologics Main Business Overview
11.15.5 AGC Biologics Latest Developments
11.16 Pfizer CentreOne
11.16.1 Pfizer CentreOne Company Information
11.16.2 Pfizer CentreOne Cell and Gene Therapy CDMO Product Offered
11.16.3 Pfizer CentreOne Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 Pfizer CentreOne Main Business Overview
11.16.5 Pfizer CentreOne Latest Developments
11.17 Almac Group
11.17.1 Almac Group Company Information
11.17.2 Almac Group Cell and Gene Therapy CDMO Product Offered
11.17.3 Almac Group Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
11.17.4 Almac Group Main Business Overview
11.17.5 Almac Group Latest Developments
11.18 PCI Pharma Services
11.18.1 PCI Pharma Services Company Information
11.18.2 PCI Pharma Services Cell and Gene Therapy CDMO Product Offered
11.18.3 PCI Pharma Services Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
11.18.4 PCI Pharma Services Main Business Overview
11.18.5 PCI Pharma Services Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Cell and Gene Therapy CDMO Market Size 2018-2029
2.1.2 Cell and Gene Therapy CDMO Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Cell and Gene Therapy CDMO Segment by Type
2.2.1 Clinical Trial Material CDMOs
2.2.2 Development and Manufacturing CDMOs
2.2.3 Other
2.3 Cell and Gene Therapy CDMO Market Size by Type
2.3.1 Cell and Gene Therapy CDMO Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Cell and Gene Therapy CDMO Market Size Market Share by Type (2018-2023)
2.4 Cell and Gene Therapy CDMO Segment by Application
2.4.1 Pharmaceutical Company
2.4.2 Biotechnology Company
2.4.3 Other
2.5 Cell and Gene Therapy CDMO Market Size by Application
2.5.1 Cell and Gene Therapy CDMO Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Cell and Gene Therapy CDMO Market Size Market Share by Application (2018-2023)
3 CELL AND GENE THERAPY CDMO MARKET SIZE BY PLAYER
3.1 Cell and Gene Therapy CDMO Market Size Market Share by Players
3.1.1 Global Cell and Gene Therapy CDMO Revenue by Players (2018-2023)
3.1.2 Global Cell and Gene Therapy CDMO Revenue Market Share by Players (2018-2023)
3.2 Global Cell and Gene Therapy CDMO Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CELL AND GENE THERAPY CDMO BY REGIONS
4.1 Cell and Gene Therapy CDMO Market Size by Regions (2018-2023)
4.2 Americas Cell and Gene Therapy CDMO Market Size Growth (2018-2023)
4.3 APAC Cell and Gene Therapy CDMO Market Size Growth (2018-2023)
4.4 Europe Cell and Gene Therapy CDMO Market Size Growth (2018-2023)
4.5 Middle East & Africa Cell and Gene Therapy CDMO Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Cell and Gene Therapy CDMO Market Size by Country (2018-2023)
5.2 Americas Cell and Gene Therapy CDMO Market Size by Type (2018-2023)
5.3 Americas Cell and Gene Therapy CDMO Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cell and Gene Therapy CDMO Market Size by Region (2018-2023)
6.2 APAC Cell and Gene Therapy CDMO Market Size by Type (2018-2023)
6.3 APAC Cell and Gene Therapy CDMO Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Cell and Gene Therapy CDMO by Country (2018-2023)
7.2 Europe Cell and Gene Therapy CDMO Market Size by Type (2018-2023)
7.3 Europe Cell and Gene Therapy CDMO Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Cell and Gene Therapy CDMO by Region (2018-2023)
8.2 Middle East & Africa Cell and Gene Therapy CDMO Market Size by Type (2018-2023)
8.3 Middle East & Africa Cell and Gene Therapy CDMO Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CELL AND GENE THERAPY CDMO MARKET FORECAST
10.1 Global Cell and Gene Therapy CDMO Forecast by Regions (2024-2029)
10.1.1 Global Cell and Gene Therapy CDMO Forecast by Regions (2024-2029)
10.1.2 Americas Cell and Gene Therapy CDMO Forecast
10.1.3 APAC Cell and Gene Therapy CDMO Forecast
10.1.4 Europe Cell and Gene Therapy CDMO Forecast
10.1.5 Middle East & Africa Cell and Gene Therapy CDMO Forecast
10.2 Americas Cell and Gene Therapy CDMO Forecast by Country (2024-2029)
10.2.1 United States Cell and Gene Therapy CDMO Market Forecast
10.2.2 Canada Cell and Gene Therapy CDMO Market Forecast
10.2.3 Mexico Cell and Gene Therapy CDMO Market Forecast
10.2.4 Brazil Cell and Gene Therapy CDMO Market Forecast
10.3 APAC Cell and Gene Therapy CDMO Forecast by Region (2024-2029)
10.3.1 China Cell and Gene Therapy CDMO Market Forecast
10.3.2 Japan Cell and Gene Therapy CDMO Market Forecast
10.3.3 Korea Cell and Gene Therapy CDMO Market Forecast
10.3.4 Southeast Asia Cell and Gene Therapy CDMO Market Forecast
10.3.5 India Cell and Gene Therapy CDMO Market Forecast
10.3.6 Australia Cell and Gene Therapy CDMO Market Forecast
10.4 Europe Cell and Gene Therapy CDMO Forecast by Country (2024-2029)
10.4.1 Germany Cell and Gene Therapy CDMO Market Forecast
10.4.2 France Cell and Gene Therapy CDMO Market Forecast
10.4.3 UK Cell and Gene Therapy CDMO Market Forecast
10.4.4 Italy Cell and Gene Therapy CDMO Market Forecast
10.4.5 Russia Cell and Gene Therapy CDMO Market Forecast
10.5 Middle East & Africa Cell and Gene Therapy CDMO Forecast by Region (2024-2029)
10.5.1 Egypt Cell and Gene Therapy CDMO Market Forecast
10.5.2 South Africa Cell and Gene Therapy CDMO Market Forecast
10.5.3 Israel Cell and Gene Therapy CDMO Market Forecast
10.5.4 Turkey Cell and Gene Therapy CDMO Market Forecast
10.5.5 GCC Countries Cell and Gene Therapy CDMO Market Forecast
10.6 Global Cell and Gene Therapy CDMO Forecast by Type (2024-2029)
10.7 Global Cell and Gene Therapy CDMO Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Lonza
11.1.1 Lonza Company Information
11.1.2 Lonza Cell and Gene Therapy CDMO Product Offered
11.1.3 Lonza Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Lonza Main Business Overview
11.1.5 Lonza Latest Developments
11.2 Charles River Laboratories
11.2.1 Charles River Laboratories Company Information
11.2.2 Charles River Laboratories Cell and Gene Therapy CDMO Product Offered
11.2.3 Charles River Laboratories Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Charles River Laboratories Main Business Overview
11.2.5 Charles River Laboratories Latest Developments
11.3 Cytiva
11.3.1 Cytiva Company Information
11.3.2 Cytiva Cell and Gene Therapy CDMO Product Offered
11.3.3 Cytiva Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Cytiva Main Business Overview
11.3.5 Cytiva Latest Developments
11.4 Catalent Biologics
11.4.1 Catalent Biologics Company Information
11.4.2 Catalent Biologics Cell and Gene Therapy CDMO Product Offered
11.4.3 Catalent Biologics Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Catalent Biologics Main Business Overview
11.4.5 Catalent Biologics Latest Developments
11.5 FUJIFILM Diosynth Biotechnologies
11.5.1 FUJIFILM Diosynth Biotechnologies Company Information
11.5.2 FUJIFILM Diosynth Biotechnologies Cell and Gene Therapy CDMO Product Offered
11.5.3 FUJIFILM Diosynth Biotechnologies Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 FUJIFILM Diosynth Biotechnologies Main Business Overview
11.5.5 FUJIFILM Diosynth Biotechnologies Latest Developments
11.6 BioCentriq
11.6.1 BioCentriq Company Information
11.6.2 BioCentriq Cell and Gene Therapy CDMO Product Offered
11.6.3 BioCentriq Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 BioCentriq Main Business Overview
11.6.5 BioCentriq Latest Developments
11.7 RoslinCT
11.7.1 RoslinCT Company Information
11.7.2 RoslinCT Cell and Gene Therapy CDMO Product Offered
11.7.3 RoslinCT Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 RoslinCT Main Business Overview
11.7.5 RoslinCT Latest Developments
11.8 Thermo Scientific
11.8.1 Thermo Scientific Company Information
11.8.2 Thermo Scientific Cell and Gene Therapy CDMO Product Offered
11.8.3 Thermo Scientific Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Thermo Scientific Main Business Overview
11.8.5 Thermo Scientific Latest Developments
11.9 Mesoblast
11.9.1 Mesoblast Company Information
11.9.2 Mesoblast Cell and Gene Therapy CDMO Product Offered
11.9.3 Mesoblast Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Mesoblast Main Business Overview
11.9.5 Mesoblast Latest Developments
11.10 Cellularity
11.10.1 Cellularity Company Information
11.10.2 Cellularity Cell and Gene Therapy CDMO Product Offered
11.10.3 Cellularity Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Cellularity Main Business Overview
11.10.5 Cellularity Latest Developments
11.11 Bluebird Bio
11.11.1 Bluebird Bio Company Information
11.11.2 Bluebird Bio Cell and Gene Therapy CDMO Product Offered
11.11.3 Bluebird Bio Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Bluebird Bio Main Business Overview
11.11.5 Bluebird Bio Latest Developments
11.12 Editas Medicine
11.12.1 Editas Medicine Company Information
11.12.2 Editas Medicine Cell and Gene Therapy CDMO Product Offered
11.12.3 Editas Medicine Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Editas Medicine Main Business Overview
11.12.5 Editas Medicine Latest Developments
11.13 Andelyn Biosciences
11.13.1 Andelyn Biosciences Company Information
11.13.2 Andelyn Biosciences Cell and Gene Therapy CDMO Product Offered
11.13.3 Andelyn Biosciences Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Andelyn Biosciences Main Business Overview
11.13.5 Andelyn Biosciences Latest Developments
11.14 Wuxi Advanced Therapies
11.14.1 Wuxi Advanced Therapies Company Information
11.14.2 Wuxi Advanced Therapies Cell and Gene Therapy CDMO Product Offered
11.14.3 Wuxi Advanced Therapies Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Wuxi Advanced Therapies Main Business Overview
11.14.5 Wuxi Advanced Therapies Latest Developments
11.15 AGC Biologics
11.15.1 AGC Biologics Company Information
11.15.2 AGC Biologics Cell and Gene Therapy CDMO Product Offered
11.15.3 AGC Biologics Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 AGC Biologics Main Business Overview
11.15.5 AGC Biologics Latest Developments
11.16 Pfizer CentreOne
11.16.1 Pfizer CentreOne Company Information
11.16.2 Pfizer CentreOne Cell and Gene Therapy CDMO Product Offered
11.16.3 Pfizer CentreOne Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 Pfizer CentreOne Main Business Overview
11.16.5 Pfizer CentreOne Latest Developments
11.17 Almac Group
11.17.1 Almac Group Company Information
11.17.2 Almac Group Cell and Gene Therapy CDMO Product Offered
11.17.3 Almac Group Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
11.17.4 Almac Group Main Business Overview
11.17.5 Almac Group Latest Developments
11.18 PCI Pharma Services
11.18.1 PCI Pharma Services Company Information
11.18.2 PCI Pharma Services Cell and Gene Therapy CDMO Product Offered
11.18.3 PCI Pharma Services Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
11.18.4 PCI Pharma Services Main Business Overview
11.18.5 PCI Pharma Services Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Cell and Gene Therapy CDMO Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Clinical Trial Material CDMOs
Table 3. Major Players of Development and Manufacturing CDMOs
Table 4. Major Players of Other
Table 5. Cell and Gene Therapy CDMO Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 6. Global Cell and Gene Therapy CDMO Market Size by Type (2018-2023) & ($ Millions)
Table 7. Global Cell and Gene Therapy CDMO Market Size Market Share by Type (2018-2023)
Table 8. Cell and Gene Therapy CDMO Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global Cell and Gene Therapy CDMO Market Size by Application (2018-2023) & ($ Millions)
Table 10. Global Cell and Gene Therapy CDMO Market Size Market Share by Application (2018-2023)
Table 11. Global Cell and Gene Therapy CDMO Revenue by Players (2018-2023) & ($ Millions)
Table 12. Global Cell and Gene Therapy CDMO Revenue Market Share by Player (2018-2023)
Table 13. Cell and Gene Therapy CDMO Key Players Head office and Products Offered
Table 14. Cell and Gene Therapy CDMO Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Cell and Gene Therapy CDMO Market Size by Regions 2018-2023 & ($ Millions)
Table 18. Global Cell and Gene Therapy CDMO Market Size Market Share by Regions (2018-2023)
Table 19. Global Cell and Gene Therapy CDMO Revenue by Country/Region (2018-2023) & ($ millions)
Table 20. Global Cell and Gene Therapy CDMO Revenue Market Share by Country/Region (2018-2023)
Table 21. Americas Cell and Gene Therapy CDMO Market Size by Country (2018-2023) & ($ Millions)
Table 22. Americas Cell and Gene Therapy CDMO Market Size Market Share by Country (2018-2023)
Table 23. Americas Cell and Gene Therapy CDMO Market Size by Type (2018-2023) & ($ Millions)
Table 24. Americas Cell and Gene Therapy CDMO Market Size Market Share by Type (2018-2023)
Table 25. Americas Cell and Gene Therapy CDMO Market Size by Application (2018-2023) & ($ Millions)
Table 26. Americas Cell and Gene Therapy CDMO Market Size Market Share by Application (2018-2023)
Table 27. APAC Cell and Gene Therapy CDMO Market Size by Region (2018-2023) & ($ Millions)
Table 28. APAC Cell and Gene Therapy CDMO Market Size Market Share by Region (2018-2023)
Table 29. APAC Cell and Gene Therapy CDMO Market Size by Type (2018-2023) & ($ Millions)
Table 30. APAC Cell and Gene Therapy CDMO Market Size Market Share by Type (2018-2023)
Table 31. APAC Cell and Gene Therapy CDMO Market Size by Application (2018-2023) & ($ Millions)
Table 32. APAC Cell and Gene Therapy CDMO Market Size Market Share by Application (2018-2023)
Table 33. Europe Cell and Gene Therapy CDMO Market Size by Country (2018-2023) & ($ Millions)
Table 34. Europe Cell and Gene Therapy CDMO Market Size Market Share by Country (2018-2023)
Table 35. Europe Cell and Gene Therapy CDMO Market Size by Type (2018-2023) & ($ Millions)
Table 36. Europe Cell and Gene Therapy CDMO Market Size Market Share by Type (2018-2023)
Table 37. Europe Cell and Gene Therapy CDMO Market Size by Application (2018-2023) & ($ Millions)
Table 38. Europe Cell and Gene Therapy CDMO Market Size Market Share by Application (2018-2023)
Table 39. Middle East & Africa Cell and Gene Therapy CDMO Market Size by Region (2018-2023) & ($ Millions)
Table 40. Middle East & Africa Cell and Gene Therapy CDMO Market Size Market Share by Region (2018-2023)
Table 41. Middle East & Africa Cell and Gene Therapy CDMO Market Size by Type (2018-2023) & ($ Millions)
Table 42. Middle East & Africa Cell and Gene Therapy CDMO Market Size Market Share by Type (2018-2023)
Table 43. Middle East & Africa Cell and Gene Therapy CDMO Market Size by Application (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Cell and Gene Therapy CDMO Market Size Market Share by Application (2018-2023)
Table 45. Key Market Drivers & Growth Opportunities of Cell and Gene Therapy CDMO
Table 46. Key Market Challenges & Risks of Cell and Gene Therapy CDMO
Table 47. Key Industry Trends of Cell and Gene Therapy CDMO
Table 48. Global Cell and Gene Therapy CDMO Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 49. Global Cell and Gene Therapy CDMO Market Size Market Share Forecast by Regions (2024-2029)
Table 50. Global Cell and Gene Therapy CDMO Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 51. Global Cell and Gene Therapy CDMO Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 52. Lonza Details, Company Type, Cell and Gene Therapy CDMO Area Served and Its Competitors
Table 53. Lonza Cell and Gene Therapy CDMO Product Offered
Table 54. Lonza Cell and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 55. Lonza Main Business
Table 56. Lonza Latest Developments
Table 57. Charles River Laboratories Details, Company Type, Cell and Gene Therapy CDMO Area Served and Its Competitors
Table 58. Charles River Laboratories Cell and Gene Therapy CDMO Product Offered
Table 59. Charles River Laboratories Main Business
Table 60. Charles River Laboratories Cell and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 61. Charles River Laboratories Latest Developments
Table 62. Cytiva Details, Company Type, Cell and Gene Therapy CDMO Area Served and Its Competitors
Table 63. Cytiva Cell and Gene Therapy CDMO Product Offered
Table 64. Cytiva Main Business
Table 65. Cytiva Cell and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 66. Cytiva Latest Developments
Table 67. Catalent Biologics Details, Company Type, Cell and Gene Therapy CDMO Area Served and Its Competitors
Table 68. Catalent Biologics Cell and Gene Therapy CDMO Product Offered
Table 69. Catalent Biologics Main Business
Table 70. Catalent Biologics Cell and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 71. Catalent Biologics Latest Developments
Table 72. FUJIFILM Diosynth Biotechnologies Details, Company Type, Cell and Gene Therapy CDMO Area Served and Its Competitors
Table 73. FUJIFILM Diosynth Biotechnologies Cell and Gene Therapy CDMO Product Offered
Table 74. FUJIFILM Diosynth Biotechnologies Main Business
Table 75. FUJIFILM Diosynth Biotechnologies Cell and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 76. FUJIFILM Diosynth Biotechnologies Latest Developments
Table 77. BioCentriq Details, Company Type, Cell and Gene Therapy CDMO Area Served and Its Competitors
Table 78. BioCentriq Cell and Gene Therapy CDMO Product Offered
Table 79. BioCentriq Main Business
Table 80. BioCentriq Cell and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 81. BioCentriq Latest Developments
Table 82. RoslinCT Details, Company Type, Cell and Gene Therapy CDMO Area Served and Its Competitors
Table 83. RoslinCT Cell and Gene Therapy CDMO Product Offered
Table 84. RoslinCT Main Business
Table 85. RoslinCT Cell and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 86. RoslinCT Latest Developments
Table 87. Thermo Scientific Details, Company Type, Cell and Gene Therapy CDMO Area Served and Its Competitors
Table 88. Thermo Scientific Cell and Gene Therapy CDMO Product Offered
Table 89. Thermo Scientific Main Business
Table 90. Thermo Scientific Cell and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 91. Thermo Scientific Latest Developments
Table 92. Mesoblast Details, Company Type, Cell and Gene Therapy CDMO Area Served and Its Competitors
Table 93. Mesoblast Cell and Gene Therapy CDMO Product Offered
Table 94. Mesoblast Main Business
Table 95. Mesoblast Cell and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 96. Mesoblast Latest Developments
Table 97. Cellularity Details, Company Type, Cell and Gene Therapy CDMO Area Served and Its Competitors
Table 98. Cellularity Cell and Gene Therapy CDMO Product Offered
Table 99. Cellularity Main Business
Table 100. Cellularity Cell and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 101. Cellularity Latest Developments
Table 102. Bluebird Bio Details, Company Type, Cell and Gene Therapy CDMO Area Served and Its Competitors
Table 103. Bluebird Bio Cell and Gene Therapy CDMO Product Offered
Table 104. Bluebird Bio Cell and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 105. Bluebird Bio Main Business
Table 106. Bluebird Bio Latest Developments
Table 107. Editas Medicine Details, Company Type, Cell and Gene Therapy CDMO Area Served and Its Competitors
Table 108. Editas Medicine Cell and Gene Therapy CDMO Product Offered
Table 109. Editas Medicine Main Business
Table 110. Editas Medicine Cell and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 111. Editas Medicine Latest Developments
Table 112. Andelyn Biosciences Details, Company Type, Cell and Gene Therapy CDMO Area Served and Its Competitors
Table 113. Andelyn Biosciences Cell and Gene Therapy CDMO Product Offered
Table 114. Andelyn Biosciences Main Business
Table 115. Andelyn Biosciences Cell and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 116. Andelyn Biosciences Latest Developments
Table 117. Wuxi Advanced Therapies Details, Company Type, Cell and Gene Therapy CDMO Area Served and Its Competitors
Table 118. Wuxi Advanced Therapies Cell and Gene Therapy CDMO Product Offered
Table 119. Wuxi Advanced Therapies Main Business
Table 120. Wuxi Advanced Therapies Cell and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 121. Wuxi Advanced Therapies Latest Developments
Table 122. AGC Biologics Details, Company Type, Cell and Gene Therapy CDMO Area Served and Its Competitors
Table 123. AGC Biologics Cell and Gene Therapy CDMO Product Offered
Table 124. AGC Biologics Main Business
Table 125. AGC Biologics Cell and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 126. AGC Biologics Latest Developments
Table 127. Pfizer CentreOne Details, Company Type, Cell and Gene Therapy CDMO Area Served and Its Competitors
Table 128. Pfizer CentreOne Cell and Gene Therapy CDMO Product Offered
Table 129. Pfizer CentreOne Main Business
Table 130. Pfizer CentreOne Cell and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 131. Pfizer CentreOne Latest Developments
Table 132. Almac Group Details, Company Type, Cell and Gene Therapy CDMO Area Served and Its Competitors
Table 133. Almac Group Cell and Gene Therapy CDMO Product Offered
Table 134. Almac Group Main Business
Table 135. Almac Group Cell and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 136. Almac Group Latest Developments
Table 137. PCI Pharma Services Details, Company Type, Cell and Gene Therapy CDMO Area Served and Its Competitors
Table 138. PCI Pharma Services Cell and Gene Therapy CDMO Product Offered
Table 139. PCI Pharma Services Main Business
Table 140. PCI Pharma Services Cell and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 141. PCI Pharma Services Latest Developments
Table 1. Cell and Gene Therapy CDMO Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Clinical Trial Material CDMOs
Table 3. Major Players of Development and Manufacturing CDMOs
Table 4. Major Players of Other
Table 5. Cell and Gene Therapy CDMO Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 6. Global Cell and Gene Therapy CDMO Market Size by Type (2018-2023) & ($ Millions)
Table 7. Global Cell and Gene Therapy CDMO Market Size Market Share by Type (2018-2023)
Table 8. Cell and Gene Therapy CDMO Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global Cell and Gene Therapy CDMO Market Size by Application (2018-2023) & ($ Millions)
Table 10. Global Cell and Gene Therapy CDMO Market Size Market Share by Application (2018-2023)
Table 11. Global Cell and Gene Therapy CDMO Revenue by Players (2018-2023) & ($ Millions)
Table 12. Global Cell and Gene Therapy CDMO Revenue Market Share by Player (2018-2023)
Table 13. Cell and Gene Therapy CDMO Key Players Head office and Products Offered
Table 14. Cell and Gene Therapy CDMO Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Cell and Gene Therapy CDMO Market Size by Regions 2018-2023 & ($ Millions)
Table 18. Global Cell and Gene Therapy CDMO Market Size Market Share by Regions (2018-2023)
Table 19. Global Cell and Gene Therapy CDMO Revenue by Country/Region (2018-2023) & ($ millions)
Table 20. Global Cell and Gene Therapy CDMO Revenue Market Share by Country/Region (2018-2023)
Table 21. Americas Cell and Gene Therapy CDMO Market Size by Country (2018-2023) & ($ Millions)
Table 22. Americas Cell and Gene Therapy CDMO Market Size Market Share by Country (2018-2023)
Table 23. Americas Cell and Gene Therapy CDMO Market Size by Type (2018-2023) & ($ Millions)
Table 24. Americas Cell and Gene Therapy CDMO Market Size Market Share by Type (2018-2023)
Table 25. Americas Cell and Gene Therapy CDMO Market Size by Application (2018-2023) & ($ Millions)
Table 26. Americas Cell and Gene Therapy CDMO Market Size Market Share by Application (2018-2023)
Table 27. APAC Cell and Gene Therapy CDMO Market Size by Region (2018-2023) & ($ Millions)
Table 28. APAC Cell and Gene Therapy CDMO Market Size Market Share by Region (2018-2023)
Table 29. APAC Cell and Gene Therapy CDMO Market Size by Type (2018-2023) & ($ Millions)
Table 30. APAC Cell and Gene Therapy CDMO Market Size Market Share by Type (2018-2023)
Table 31. APAC Cell and Gene Therapy CDMO Market Size by Application (2018-2023) & ($ Millions)
Table 32. APAC Cell and Gene Therapy CDMO Market Size Market Share by Application (2018-2023)
Table 33. Europe Cell and Gene Therapy CDMO Market Size by Country (2018-2023) & ($ Millions)
Table 34. Europe Cell and Gene Therapy CDMO Market Size Market Share by Country (2018-2023)
Table 35. Europe Cell and Gene Therapy CDMO Market Size by Type (2018-2023) & ($ Millions)
Table 36. Europe Cell and Gene Therapy CDMO Market Size Market Share by Type (2018-2023)
Table 37. Europe Cell and Gene Therapy CDMO Market Size by Application (2018-2023) & ($ Millions)
Table 38. Europe Cell and Gene Therapy CDMO Market Size Market Share by Application (2018-2023)
Table 39. Middle East & Africa Cell and Gene Therapy CDMO Market Size by Region (2018-2023) & ($ Millions)
Table 40. Middle East & Africa Cell and Gene Therapy CDMO Market Size Market Share by Region (2018-2023)
Table 41. Middle East & Africa Cell and Gene Therapy CDMO Market Size by Type (2018-2023) & ($ Millions)
Table 42. Middle East & Africa Cell and Gene Therapy CDMO Market Size Market Share by Type (2018-2023)
Table 43. Middle East & Africa Cell and Gene Therapy CDMO Market Size by Application (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Cell and Gene Therapy CDMO Market Size Market Share by Application (2018-2023)
Table 45. Key Market Drivers & Growth Opportunities of Cell and Gene Therapy CDMO
Table 46. Key Market Challenges & Risks of Cell and Gene Therapy CDMO
Table 47. Key Industry Trends of Cell and Gene Therapy CDMO
Table 48. Global Cell and Gene Therapy CDMO Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 49. Global Cell and Gene Therapy CDMO Market Size Market Share Forecast by Regions (2024-2029)
Table 50. Global Cell and Gene Therapy CDMO Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 51. Global Cell and Gene Therapy CDMO Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 52. Lonza Details, Company Type, Cell and Gene Therapy CDMO Area Served and Its Competitors
Table 53. Lonza Cell and Gene Therapy CDMO Product Offered
Table 54. Lonza Cell and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 55. Lonza Main Business
Table 56. Lonza Latest Developments
Table 57. Charles River Laboratories Details, Company Type, Cell and Gene Therapy CDMO Area Served and Its Competitors
Table 58. Charles River Laboratories Cell and Gene Therapy CDMO Product Offered
Table 59. Charles River Laboratories Main Business
Table 60. Charles River Laboratories Cell and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 61. Charles River Laboratories Latest Developments
Table 62. Cytiva Details, Company Type, Cell and Gene Therapy CDMO Area Served and Its Competitors
Table 63. Cytiva Cell and Gene Therapy CDMO Product Offered
Table 64. Cytiva Main Business
Table 65. Cytiva Cell and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 66. Cytiva Latest Developments
Table 67. Catalent Biologics Details, Company Type, Cell and Gene Therapy CDMO Area Served and Its Competitors
Table 68. Catalent Biologics Cell and Gene Therapy CDMO Product Offered
Table 69. Catalent Biologics Main Business
Table 70. Catalent Biologics Cell and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 71. Catalent Biologics Latest Developments
Table 72. FUJIFILM Diosynth Biotechnologies Details, Company Type, Cell and Gene Therapy CDMO Area Served and Its Competitors
Table 73. FUJIFILM Diosynth Biotechnologies Cell and Gene Therapy CDMO Product Offered
Table 74. FUJIFILM Diosynth Biotechnologies Main Business
Table 75. FUJIFILM Diosynth Biotechnologies Cell and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 76. FUJIFILM Diosynth Biotechnologies Latest Developments
Table 77. BioCentriq Details, Company Type, Cell and Gene Therapy CDMO Area Served and Its Competitors
Table 78. BioCentriq Cell and Gene Therapy CDMO Product Offered
Table 79. BioCentriq Main Business
Table 80. BioCentriq Cell and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 81. BioCentriq Latest Developments
Table 82. RoslinCT Details, Company Type, Cell and Gene Therapy CDMO Area Served and Its Competitors
Table 83. RoslinCT Cell and Gene Therapy CDMO Product Offered
Table 84. RoslinCT Main Business
Table 85. RoslinCT Cell and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 86. RoslinCT Latest Developments
Table 87. Thermo Scientific Details, Company Type, Cell and Gene Therapy CDMO Area Served and Its Competitors
Table 88. Thermo Scientific Cell and Gene Therapy CDMO Product Offered
Table 89. Thermo Scientific Main Business
Table 90. Thermo Scientific Cell and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 91. Thermo Scientific Latest Developments
Table 92. Mesoblast Details, Company Type, Cell and Gene Therapy CDMO Area Served and Its Competitors
Table 93. Mesoblast Cell and Gene Therapy CDMO Product Offered
Table 94. Mesoblast Main Business
Table 95. Mesoblast Cell and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 96. Mesoblast Latest Developments
Table 97. Cellularity Details, Company Type, Cell and Gene Therapy CDMO Area Served and Its Competitors
Table 98. Cellularity Cell and Gene Therapy CDMO Product Offered
Table 99. Cellularity Main Business
Table 100. Cellularity Cell and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 101. Cellularity Latest Developments
Table 102. Bluebird Bio Details, Company Type, Cell and Gene Therapy CDMO Area Served and Its Competitors
Table 103. Bluebird Bio Cell and Gene Therapy CDMO Product Offered
Table 104. Bluebird Bio Cell and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 105. Bluebird Bio Main Business
Table 106. Bluebird Bio Latest Developments
Table 107. Editas Medicine Details, Company Type, Cell and Gene Therapy CDMO Area Served and Its Competitors
Table 108. Editas Medicine Cell and Gene Therapy CDMO Product Offered
Table 109. Editas Medicine Main Business
Table 110. Editas Medicine Cell and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 111. Editas Medicine Latest Developments
Table 112. Andelyn Biosciences Details, Company Type, Cell and Gene Therapy CDMO Area Served and Its Competitors
Table 113. Andelyn Biosciences Cell and Gene Therapy CDMO Product Offered
Table 114. Andelyn Biosciences Main Business
Table 115. Andelyn Biosciences Cell and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 116. Andelyn Biosciences Latest Developments
Table 117. Wuxi Advanced Therapies Details, Company Type, Cell and Gene Therapy CDMO Area Served and Its Competitors
Table 118. Wuxi Advanced Therapies Cell and Gene Therapy CDMO Product Offered
Table 119. Wuxi Advanced Therapies Main Business
Table 120. Wuxi Advanced Therapies Cell and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 121. Wuxi Advanced Therapies Latest Developments
Table 122. AGC Biologics Details, Company Type, Cell and Gene Therapy CDMO Area Served and Its Competitors
Table 123. AGC Biologics Cell and Gene Therapy CDMO Product Offered
Table 124. AGC Biologics Main Business
Table 125. AGC Biologics Cell and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 126. AGC Biologics Latest Developments
Table 127. Pfizer CentreOne Details, Company Type, Cell and Gene Therapy CDMO Area Served and Its Competitors
Table 128. Pfizer CentreOne Cell and Gene Therapy CDMO Product Offered
Table 129. Pfizer CentreOne Main Business
Table 130. Pfizer CentreOne Cell and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 131. Pfizer CentreOne Latest Developments
Table 132. Almac Group Details, Company Type, Cell and Gene Therapy CDMO Area Served and Its Competitors
Table 133. Almac Group Cell and Gene Therapy CDMO Product Offered
Table 134. Almac Group Main Business
Table 135. Almac Group Cell and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 136. Almac Group Latest Developments
Table 137. PCI Pharma Services Details, Company Type, Cell and Gene Therapy CDMO Area Served and Its Competitors
Table 138. PCI Pharma Services Cell and Gene Therapy CDMO Product Offered
Table 139. PCI Pharma Services Main Business
Table 140. PCI Pharma Services Cell and Gene Therapy CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 141. PCI Pharma Services Latest Developments
LIST OF FIGURES
Figure 1. Cell and Gene Therapy CDMO Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Cell and Gene Therapy CDMO Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Cell and Gene Therapy CDMO Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Cell and Gene Therapy CDMO Sales Market Share by Country/Region (2022)
Figure 8. Cell and Gene Therapy CDMO Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Cell and Gene Therapy CDMO Market Size Market Share by Type in 2022
Figure 10. Cell and Gene Therapy CDMO in Pharmaceutical Company
Figure 11. Global Cell and Gene Therapy CDMO Market: Pharmaceutical Company (2018-2023) & ($ Millions)
Figure 12. Cell and Gene Therapy CDMO in Biotechnology Company
Figure 13. Global Cell and Gene Therapy CDMO Market: Biotechnology Company (2018-2023) & ($ Millions)
Figure 14. Cell and Gene Therapy CDMO in Other
Figure 15. Global Cell and Gene Therapy CDMO Market: Other (2018-2023) & ($ Millions)
Figure 16. Global Cell and Gene Therapy CDMO Market Size Market Share by Application in 2022
Figure 17. Global Cell and Gene Therapy CDMO Revenue Market Share by Player in 2022
Figure 18. Global Cell and Gene Therapy CDMO Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Cell and Gene Therapy CDMO Market Size 2018-2023 ($ Millions)
Figure 20. APAC Cell and Gene Therapy CDMO Market Size 2018-2023 ($ Millions)
Figure 21. Europe Cell and Gene Therapy CDMO Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Cell and Gene Therapy CDMO Market Size 2018-2023 ($ Millions)
Figure 23. Americas Cell and Gene Therapy CDMO Value Market Share by Country in 2022
Figure 24. United States Cell and Gene Therapy CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Cell and Gene Therapy CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Cell and Gene Therapy CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Cell and Gene Therapy CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Cell and Gene Therapy CDMO Market Size Market Share by Region in 2022
Figure 29. APAC Cell and Gene Therapy CDMO Market Size Market Share by Type in 2022
Figure 30. APAC Cell and Gene Therapy CDMO Market Size Market Share by Application in 2022
Figure 31. China Cell and Gene Therapy CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Cell and Gene Therapy CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Cell and Gene Therapy CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Cell and Gene Therapy CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Cell and Gene Therapy CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Cell and Gene Therapy CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Cell and Gene Therapy CDMO Market Size Market Share by Country in 2022
Figure 38. Europe Cell and Gene Therapy CDMO Market Size Market Share by Type (2018-2023)
Figure 39. Europe Cell and Gene Therapy CDMO Market Size Market Share by Application (2018-2023)
Figure 40. Germany Cell and Gene Therapy CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Cell and Gene Therapy CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Cell and Gene Therapy CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Cell and Gene Therapy CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Cell and Gene Therapy CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Cell and Gene Therapy CDMO Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Cell and Gene Therapy CDMO Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Cell and Gene Therapy CDMO Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Cell and Gene Therapy CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Cell and Gene Therapy CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Cell and Gene Therapy CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Cell and Gene Therapy CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Cell and Gene Therapy CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Cell and Gene Therapy CDMO Market Size 2024-2029 ($ Millions)
Figure 54. APAC Cell and Gene Therapy CDMO Market Size 2024-2029 ($ Millions)
Figure 55. Europe Cell and Gene Therapy CDMO Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Cell and Gene Therapy CDMO Market Size 2024-2029 ($ Millions)
Figure 57. United States Cell and Gene Therapy CDMO Market Size 2024-2029 ($ Millions)
Figure 58. Canada Cell and Gene Therapy CDMO Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Cell and Gene Therapy CDMO Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Cell and Gene Therapy CDMO Market Size 2024-2029 ($ Millions)
Figure 61. China Cell and Gene Therapy CDMO Market Size 2024-2029 ($ Millions)
Figure 62. Japan Cell and Gene Therapy CDMO Market Size 2024-2029 ($ Millions)
Figure 63. Korea Cell and Gene Therapy CDMO Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Cell and Gene Therapy CDMO Market Size 2024-2029 ($ Millions)
Figure 65. India Cell and Gene Therapy CDMO Market Size 2024-2029 ($ Millions)
Figure 66. Australia Cell and Gene Therapy CDMO Market Size 2024-2029 ($ Millions)
Figure 67. Germany Cell and Gene Therapy CDMO Market Size 2024-2029 ($ Millions)
Figure 68. France Cell and Gene Therapy CDMO Market Size 2024-2029 ($ Millions)
Figure 69. UK Cell and Gene Therapy CDMO Market Size 2024-2029 ($ Millions)
Figure 70. Italy Cell and Gene Therapy CDMO Market Size 2024-2029 ($ Millions)
Figure 71. Russia Cell and Gene Therapy CDMO Market Size 2024-2029 ($ Millions)
Figure 72. Spain Cell and Gene Therapy CDMO Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Cell and Gene Therapy CDMO Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Cell and Gene Therapy CDMO Market Size 2024-2029 ($ Millions)
Figure 75. Israel Cell and Gene Therapy CDMO Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Cell and Gene Therapy CDMO Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Cell and Gene Therapy CDMO Market Size 2024-2029 ($ Millions)
Figure 78. Global Cell and Gene Therapy CDMO Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Cell and Gene Therapy CDMO Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Cell and Gene Therapy CDMO Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Cell and Gene Therapy CDMO Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Cell and Gene Therapy CDMO Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Cell and Gene Therapy CDMO Sales Market Share by Country/Region (2022)
Figure 8. Cell and Gene Therapy CDMO Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Cell and Gene Therapy CDMO Market Size Market Share by Type in 2022
Figure 10. Cell and Gene Therapy CDMO in Pharmaceutical Company
Figure 11. Global Cell and Gene Therapy CDMO Market: Pharmaceutical Company (2018-2023) & ($ Millions)
Figure 12. Cell and Gene Therapy CDMO in Biotechnology Company
Figure 13. Global Cell and Gene Therapy CDMO Market: Biotechnology Company (2018-2023) & ($ Millions)
Figure 14. Cell and Gene Therapy CDMO in Other
Figure 15. Global Cell and Gene Therapy CDMO Market: Other (2018-2023) & ($ Millions)
Figure 16. Global Cell and Gene Therapy CDMO Market Size Market Share by Application in 2022
Figure 17. Global Cell and Gene Therapy CDMO Revenue Market Share by Player in 2022
Figure 18. Global Cell and Gene Therapy CDMO Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Cell and Gene Therapy CDMO Market Size 2018-2023 ($ Millions)
Figure 20. APAC Cell and Gene Therapy CDMO Market Size 2018-2023 ($ Millions)
Figure 21. Europe Cell and Gene Therapy CDMO Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Cell and Gene Therapy CDMO Market Size 2018-2023 ($ Millions)
Figure 23. Americas Cell and Gene Therapy CDMO Value Market Share by Country in 2022
Figure 24. United States Cell and Gene Therapy CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Cell and Gene Therapy CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Cell and Gene Therapy CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Cell and Gene Therapy CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Cell and Gene Therapy CDMO Market Size Market Share by Region in 2022
Figure 29. APAC Cell and Gene Therapy CDMO Market Size Market Share by Type in 2022
Figure 30. APAC Cell and Gene Therapy CDMO Market Size Market Share by Application in 2022
Figure 31. China Cell and Gene Therapy CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Cell and Gene Therapy CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Cell and Gene Therapy CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Cell and Gene Therapy CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Cell and Gene Therapy CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Cell and Gene Therapy CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Cell and Gene Therapy CDMO Market Size Market Share by Country in 2022
Figure 38. Europe Cell and Gene Therapy CDMO Market Size Market Share by Type (2018-2023)
Figure 39. Europe Cell and Gene Therapy CDMO Market Size Market Share by Application (2018-2023)
Figure 40. Germany Cell and Gene Therapy CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Cell and Gene Therapy CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Cell and Gene Therapy CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Cell and Gene Therapy CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Cell and Gene Therapy CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Cell and Gene Therapy CDMO Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Cell and Gene Therapy CDMO Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Cell and Gene Therapy CDMO Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Cell and Gene Therapy CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Cell and Gene Therapy CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Cell and Gene Therapy CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Cell and Gene Therapy CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Cell and Gene Therapy CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Cell and Gene Therapy CDMO Market Size 2024-2029 ($ Millions)
Figure 54. APAC Cell and Gene Therapy CDMO Market Size 2024-2029 ($ Millions)
Figure 55. Europe Cell and Gene Therapy CDMO Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Cell and Gene Therapy CDMO Market Size 2024-2029 ($ Millions)
Figure 57. United States Cell and Gene Therapy CDMO Market Size 2024-2029 ($ Millions)
Figure 58. Canada Cell and Gene Therapy CDMO Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Cell and Gene Therapy CDMO Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Cell and Gene Therapy CDMO Market Size 2024-2029 ($ Millions)
Figure 61. China Cell and Gene Therapy CDMO Market Size 2024-2029 ($ Millions)
Figure 62. Japan Cell and Gene Therapy CDMO Market Size 2024-2029 ($ Millions)
Figure 63. Korea Cell and Gene Therapy CDMO Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Cell and Gene Therapy CDMO Market Size 2024-2029 ($ Millions)
Figure 65. India Cell and Gene Therapy CDMO Market Size 2024-2029 ($ Millions)
Figure 66. Australia Cell and Gene Therapy CDMO Market Size 2024-2029 ($ Millions)
Figure 67. Germany Cell and Gene Therapy CDMO Market Size 2024-2029 ($ Millions)
Figure 68. France Cell and Gene Therapy CDMO Market Size 2024-2029 ($ Millions)
Figure 69. UK Cell and Gene Therapy CDMO Market Size 2024-2029 ($ Millions)
Figure 70. Italy Cell and Gene Therapy CDMO Market Size 2024-2029 ($ Millions)
Figure 71. Russia Cell and Gene Therapy CDMO Market Size 2024-2029 ($ Millions)
Figure 72. Spain Cell and Gene Therapy CDMO Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Cell and Gene Therapy CDMO Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Cell and Gene Therapy CDMO Market Size 2024-2029 ($ Millions)
Figure 75. Israel Cell and Gene Therapy CDMO Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Cell and Gene Therapy CDMO Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Cell and Gene Therapy CDMO Market Size 2024-2029 ($ Millions)
Figure 78. Global Cell and Gene Therapy CDMO Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Cell and Gene Therapy CDMO Market Size Market Share Forecast by Application (2024-2029)
